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ABSTRACT: The molecular alterations involved in the capsule deformation presented in shoulder instability patients are poorly
understood. Increased TGFb1 acts as a signal for production of matrix macromolecules by fibrogenic cells at joint injury sites. TGFb1,
through its receptor TGFbR1, regulates genes involved in collagen cross-linking, such as LOX, PLOD1, and PLOD2. We evaluated
TGFb1, TGFbR1, LOX,PLOD1, and PLOD2 gene expression in the antero-inferior (macroscopically injured region), antero-superior
and posterior regions of the glenohumeral capsule of 29 shoulder instability patients and eight controls. We observed that PLOD2
expression was increased in the anterior-inferior capsule region of the patients compared to controls. LOX expression tended to be
increased in the posterior portion of patients. Patients with recurrent shoulder dislocation presented upregulation of TGFbR1 in the
antero-inferior capsule portion and of PLOD2 in the posterior region. Conversely, LOX was increased in the posterior portion of
the capsule of patients with a single shoulder dislocation episode. In the antero-inferior, LOX expression was inversely correlated and
TGFbR1 was directly correlated with the duration of symptoms. In the posterior region, PLOD2, TGFb1, and TGFbR1 were directly
correlated with the duration of symptoms. In conclusion, PLOD2 expression was increased in the macroscopically injured region of the
capsule of patients. Upregulation of TGFb1, TGFbR1, and PLOD2 seems to be related with the maintenance of disease symptoms,
especially in the posterior region. LOX upregulation seems to occur only in the initial phase of the affection. Therefore, TGFb1,
TGFbR1, LOX, and PLOD2 may play a role in shoulder instability.  2015 Orthopaedic Research Society. Published by Wiley
Periodicals, Inc. J Orthop Res 34:510–517, 2016.
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Shoulder dislocation is a common reason for emergency
room visits and accounts for about 45% of all
dislocations.1 Traumatic shoulder dislocations are far
more common than intentional and/or non-traumatic
forms, which are managed by rehabilitation therapy
and are not considered herein. Anterior shoulder
dislocations contribute 96–98% of all shoulder disloca-
tions.1 The incidence of first-time anterior shoulder
dislocation ranges from 8 to 8.2/100,000 population/
year and the prevalence is about 2%.1 Shoulder
instability (SI) is often observed after the initial
episode of shoulder dislocation, with a recurrence rate
of up to 100% in young athletes.2,3
Wound healing is a complex process that requires
deposition and accumulation of newly synthesized
structural proteins as well as degradation of old or
damaged structures composed mainly of the extracel-
lular matrix (ECM).4 In a previous study, we observed
deregulated expression of collagen genes across the
capsule of patients with traumatic anterior shoulder
instability.5 The expression of collagen genes were
increased in the antero-inferior (AI), antero-superior
(AS), and posterior (P) portions of the capsule in
patients compared to controls. These molecular alter-
ations may have a role in collagen fibril structure and
in the tissue healing process.
An inflammatory response commonly occurs in the
earliest phase of wound healing, followed by new
connective tissue matrix deposition.6 Increases of
transforming growth factor b1 (TGFb1) accompany
the acute inflammatory phase and appear to act as a
signal modulating the production of matrix macro-
molecules by fibrogenic cells at the injury site.7
The TGFb is activated by proteolytic cleavage.8 This
activity is mediated by 2 signaling receptors, TGFb
receptor I (TGFb1) and TGFb receptor 2 (TGFbR2),
which dimerize and transduce their signal via their
serine threonine kinase activity.9 TGFBR1 is the
central propagator of TGFb signaling.10
In the shoulder capsule of patients with adhesive
capsulitis, TGFb was associated with fibrosis and
accumulation of a dense matrix of type I and type III
collagen within the capsule.11,12 Moreover, several
studies reported similar molecular alterations in adhe-
sive capsulitis and Dupuytren disease. In Dupuytren
disease, the increased expression of TGFb1 and its
receptor TGFbR1 has previously been described.13,14
TGFb1 regulates important collagen-modifying
enzymes, such as the lysyl oxidase (LOX)15 and lysyl
hydroxylases 1 and 2 (encoded by PLOD1 e PLOD2
genes, respectively).16–18 LOX plays a key role in the
maturation of the ECM. LOX is a secreted, copper-
dependent amine oxidase which plays a substantial
role in the biogenesis of the connective tissue matrix
by oxidizing lysine residues in elastin and collagen,
thereby initiating the formation of covalent cross-links
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which stabilize these fibrous proteins.19,20 LOX activity
is essential to maintain the tensile and elastic
features of connective tissues.20,21 In many pathologi-
cal fibrotic situations, the expression of the cross-
linked enzyme LOX and its enzymatic activity are
controlled by TGFb1.15 Additionally, differential varia-
tions of TGFb1 were able to induce the LOX activity in
an in vitro model of mechanical injury in ligament
cells.22
The lysyl hydroxylases promote ECM structural
stability and maturation by promoting inter- and
intramolecular cross-links and the addition of carbohy-
drate moieties to ECM molecules.23,24 Patients with
Ehlers–Danlos Syndrome (EDS) type VI present muta-
tions in the PLOD1 gene, which result in reduced
activity of this lysyl hydroxylase. EDS type six is a
heritable disorder characterized by kyphoscoliosis,
joint laxity, skin fragility, and muscle hypertonia.25
Therefore, PLOD1 has an important role in joint
tissue structure and function. PLOD2 is implicated in
several pathological processes, including fibrosis. The
increased expression of PLOD2 was described in
fibroblasts isolated from keloid, hypertrophic scars,
and the palmar fascia of patients with Dupuytren
disease.26 Furthermore, some patients with EDS also
present reduced PLOD2 expression in skin fibro-
blasts.27 To our knowledge, no lysyl oxidase, or
hydroxylase has been implicated in normal or patho-
logical processes in the glenohumeral capsule.
We hypothesized that gene expression alterations
may arise as a result of shoulder dislocation and might
be a contributor to recurrent dislocation episodes. We
therefore evaluated, for the first time in literature, the
expression of TGFb1, TGFbR1, LOX, PLOD1, and
PLOD2 mRNA in three regions of the glenohumeral
capsule in patients with traumatic anterior shoulder
instability and controls. Moreover, we investigated the
possible associations between gene expression in
capsule samples and preoperative clinical parameters.
METHODS
This is a case-control study (level of evidence three) in which
samples of patients with and without shoulder instability
were evaluated.
Patients
We evaluated 29 outpatients with traumatic anterior
shoulder dislocation from S~ao Paulo Hospital of the
Federal University of S~ao Paulo (UNIFESP), Brazil. All
patients were treated for at least 2 weeks with shoulder
immobilization after the first episode of shoulder disloca-
tion and underwent arthroscopic surgical treatment for
shoulder instability. The following inclusion criteria were
employed: positive apprehension test, a Bankart lesion on
magnetic resonance imaging and no history of previous
surgery for an injured shoulder. Patients with clinical
signs of posterior and/or multidirectional instability or
presenting generalized joint hyperlaxity or hypermobility
by Beighton score28 were excluded. Moreover, patients
with associated lesions, such as superior lesion anterior
posterior (SLAP) lesions detected during the surgery,
were excluded.
In addition, eight subjects who underwent arthroscopi-
cally assisted treatment for acromioclavicular dislocation
were included as a control group. These patients did not
present any history of shoulder instability or positive signs
for this injury under anesthesia. Moreover, we did not find
any radiological indications of glenohumeral capsule alter-
ations. A standard complete joint examination with scope
and probe during arthroscopy confirmed that the controls did
not present any other concomitant pathology in the shoulder.
All controls were physically active.
Informed consent and the approval of the ethics commit-
tee of the UNIFESP were obtained (approval number: CEP
51436) from all patients before data and sample collection. A
preoperative questionnaire was given to all patients that
included questions regarding demographics, age of onset,
number of luxation episodes, duration of symptoms, physical
activity, type of work, and other clinical variables. In our
sample, physical activity involving the upper limbs included
basketball, handball, tennis, swimming, climbing, and the
some martial arts (judo, jiu–jitsu and capoeira, a Brazilian
martial art).
Tissue Samples
During the arthroscopic procedure, tissue samples were
obtained from three sites of the glenohumeral capsule of
each patient: AI, AS, and P sites. To minimize the variation
of sampling, the tissue specimens were taken by two of the
authors (PSB and BE).
The samples were collected as previously described by our
group.29 The biopsy samples of AI and AS sites were obtained
with the scope in the posterior portal and the basket grasper
in the anterior portal. The AI specimen was taken from the
most inferior region of the glenohumeral capsule next to the
inferior glenohumeral ligament. The AS specimen was taken
in the direction of the anterior portal, below the biceps
tendon, in the rotator interval area. The P specimen was
obtained during the evaluation of the posterior capsulolabral
complex with the scope in the anterior portal and the basket
grasper in the posterior portal. The P sample was taken in
the direction of the posterior portal.
All tissue specimens were immediately immersed in
RNAlater
1
solution (Qiagen, Germany) and then stored at
20˚C until RNA extraction.
RNA Extraction
Total RNA was extracted with an RNeasy
1
mini kit (Qiagen,
Germany) following the manufacturer’s instructions. The
mechanical lysis step was performed using the Tissue Lyser
LT equipment (Qiagen, Germany). RNA concentration and
quality were determined using a NanoDrop ND-1,000 spec-
trophotometer (Thermo Scientifc, Wilmington, DE), and RNA
integrity was verified by 1% agarose gel electrophoresis.
Aliquots of the total RNA were stored at 80˚C until further
use.
mRNA Expression Analysis
Gene expression was evaluated by reverse-transcription
quantitative polymerase chain reaction (RT-qPCR), which is
currently considered to be the gold standard technique for
the analysis of mRNA level.30 First, cDNA was synthesized
using a High-Capacity cDNA Archive kit (Life Technologies,
Foster City, CA) according to the manufacturer’s protocol.
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To detect the range of expression of the studied genes,
reactions were performed with 80–100ng of cDNA input
using TaqMan Low-Density Array (TLDA) cards (Life Tech-
nologies, Foster City, CA) and ViiA 7 Real-Time PCR System
(Life Technologies, Foster City, CA). Only inventoried Taq-
Man Gene Expression Assays (Life Technologies, Foster City,
CA) were chosen for gene expression analysis. The final
volume in each TLDA well is approximately 1ml.
The HPRT1 and B2M genes were used as internal controls
to normalize the sample input amount, based on our previous
study that identified suitable reference genes for the gene
expression studies in glenohumeral capsule.31 All qRT-PCR
reactions were performed in triplicate for all target genes (LOX:
Hs00942480_m1; PLOD1: Hs00609368_m1; PLOD2: Hs011181
90_m1; TGFb1: Hs00998133_m1; TGFbR1: Hs00610320_m1)
and reference genes (HPRT1: Hs02800695_m1; B2M: Hs00984
230_m1). For each sample, the target and reference genes were
assayed on the same card to exclude technical variations.
The relative threshold method (Crt method) was applied,
which is a robust method that sets a threshold for each curve
individually, based on the shape of the amplification curve,
regardless of the height, or variability of the curve during its
early baseline fluorescence. The expression of collagen genes
across the samples was calculated using the equation DCrt,
in which [DCrt¼ target gene Crt—the mean of reference
genes Crt]. A lower cycle threshold value (Crt) indicates
higher gene expression.
Statistical Analysis
All gene expression data (DCrt) are shown as the median
with the interquartile range (IQR).
We verified the distribution of all continuous variables
using the Shapiro–Wilk normality test to determine the
appropriate tests for subsequent statistical comparisons. The
expression data were not normally distributed. Therefore,
the Mann–Whitney test was performed to compare the gene
expression between the studied groups and clinical variables,
such as gender, number of injuries (1 dislocation episode
versus > 1 dislocation episode), practice of physical activity
involving the upper limbs and type of job (manual versus
non-manual job). A x2 test was used to compare the gender
distribution between cases and controls. Spearman’s correla-
tion was applied to evaluate the possible correlation between
gene expression and age at surgery or duration of symptoms.
A p-value of < 0.05 was considered statistically significant.
RESULTS
Patient Data and Clinical Outcomes
Table 1 shows the clinical outcomes of the shoulder
instability patients. In our experimental group,
68.8% of patients with shoulder instability for less
than one year (time between the onset and surgery)
presented two or more dislocation episodes, whereas
92.3% of patients with shoulder instability for more
than one year presented two or more dislocation
episodes. The duration of the symptoms was associat-
ed with the number of dislocation episodes (p¼ 0.008,
Mann–Whitney test).
Although no histological assessment was performed,
a macroscopic evaluation during the arthroscopic
procedure revealed that all shoulder instability
patients presented a more flexible capsular aspect in
the AI site.
Among the controls, 7 (87.5%) were males and 1
(12.5%) was female, and the median age at time of
surgery was 31.44 years (IQR¼13.5). No significant
difference was observed in the distribution of gender
between the groups (p¼ 1). In addition, age at the
time of surgery was not significantly different between
the patients and controls (p¼ 0.571, Mann–Whitney
test).
Differences Between the Cases and Controls
Table 2 shows the median and interquartile range of
TGFb1, TGFbR1, LOX, PLOD1, and PLOD2 expres-
sion in the AI, AS, and P sites of the glenohumeral
capsule in the patients and controls. The shoulder
instability patients presented increased PLOD2
expression in the AI portion of the capsule compared
to the controls (p¼ 0.020). Moreover, LOX expression
tended to be increased in the P portion of the capsule
in the studied patients (p¼ 0.058). No other significant
differences between the samples of cases and controls
were detected (p>0.05).
Gene Expression and Clinical Variables of Shoulder
Instability Patients
LOX expression was increased [2.57 (1.39) vs 4.51
(0.40); p¼ 0.048] and TGFbR1 was reduced [1.45 (0.43)
vs 0.99 (0.01); p¼ 0.048] in the AI portion of the
capsule of male compared to female patients. However,
only two patients were female.
With regard to the number of injuries, TGFbR1
expression was increased in the AI portion of the
capsule in patients with recurrent shoulder disloca-
tion compared to patients with a single episode of
shoulder dislocation [1.37 (0.32) vs 1.70 (0.74);
p¼ 0.010; Figure 1A]. In the P portion of the
capsule, PLOD2 was also upregulated in patients
with recurrent shoulder dislocation [2.53 (0.58) vs
2.78 (0.45); p¼ 0.049; Figure 1B]. Conversely, LOX
was increased in the P portion of the capsule of
patients with a single shoulder dislocation episode
[2.02 (0.703) vs 2.68 (1.54); p¼ 0.025; Figure 1C].
Furthermore, patients with only one dislocation
episode presented increased expression of LOX in
the P region of the capsule compared with controls
[2.02 (0.703) vs 3.36 (1.44); p¼0.007]. The expres-
sion of LOX did not differ between patients with
recurrent shoulder dislocations episodes and con-
trols (p> 0.05, for all capsule regions).
In the AI region of the capsule, the expression of
LOX (r¼ 0.421; p¼0.029; Figure 2A) and TGFbR1
(r¼0.479, p¼0.012; Figure 2B) were correlated
with the duration of symptoms. In the P region of
the capsule, the expression of PLOD2 (r¼0.465;
p¼ 0.025; Figure 2C), TGFb1 (r¼0.425, p¼0.043;
Figure 2D) and TGFbR1 (r¼0.446, p¼0.032;
Figure 2E) were correlated with the duration of
symptoms.
Patients who engage in physical activity involving
the upper limbs presented reduced PLOD1 expression
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in the AS portion of the capsule [1.31 (0.18) vs 1.06
(0.72); p¼ 0.045; Figure 3A]. In the P portion of the
capsule, PLOD2 expression was also reduced in
patients who engage in physical activity involving the
upper limbs compared to those that did not practice
this type of physical activity [2.75 (0.74) vs 2.44 (0.38);
p¼ 0.033; Figure 3B]. A tendency of reduced TGFb1
expression in the P portion of the capsule was also
observed in these patients [1.02 (0.60) vs 0.76 (0.48);
p¼ 0.055; Figure 3C].
No association between the expression of the stud-
ied genes and any other clinical variable was found in
shoulder instability patients (p>0.05).
DISCUSSION
The AI portion of the glenohumeral capsule of
shoulder instability patients commonly exhibits
macroscopic alteration,32,33 such as the capsular
deformation that was detected during surgical treat-
ment in all the studied patients. In the present
study, we found that PLOD2 expression was in-
creased in the AI portion of the capsule of patients
compared with controls. In several connective tis-
sues (for example, bone, tendon, ligaments, and
cartilage)24 and in fibrotic skin, the formation of
collagen cross-links occur by the hydroxyallysine
route.24,34 In this pathway, a hydroxylysine residue
in the collagen telopeptide (the terminal non-triple
helical domain) is converted into aldehyde hydrox-
yallysine. Subsequently, the hydroxyallysine reacts
with a hydroxylysine residue in the collagen triple
helix to form functional cross-links. In contrast to
PLOD1, PLOD2 is a lysyl hydroxylase that hydrox-
ylates the telopeptides.34 Therefore, the shoulder
dislocation episode may lead to PLOD2 up-regula-
tion in an attempt to heal the capsule through the
cross-linking of the new collagen fibrils by the
hydroxyallysine route in the injured tissue.
Although we did not observe a significant differ-
ence between cases and controls in the P portion of
the glenohumeral capsule, patients with more than
two episodes of shoulder dislocation and with longer
duration of symptoms presented increased expres-
sion of PLOD2 in this capsule region. There is a
reciprocal load-sharing relationship in the capsule,
whereby tensile load in either the anterior or
superior structures is simultaneously accompanied
by laxity in the P or inferior portion, respectively.33
The P region of the capsule of anterior shoulder
instability patients also presents upregulation of
COL1A1, COL1A2, COL3A1,5 and other non-colla-
gen ECM genes (unpublished data). Thus, our
results reinforce the idea that the molecular alter-
ations noted in the P region of the capsule may be
Table 1. Distribution of the Clinical Outcomes of
Shoulder Instability Patients
Variable Distribution
Age at surgery, years
[median (IQR)
28.5 (9)
Age of onset, years [median (IQR) 25 (9)
Gender [N (%)]
Male 27 (93.1)
Female 2 (6.9)
Duration of condition, years
[median (IQR)]
1 (2.1)
Duration of condition [N (%)]
 1 year 16 (55.2)
> 1 year 13 (44.8)
Number of injuries [N (%)]
1 dislocation 6 (20.7)
> 1 dislocation 23 (79.3)
Physical activity involving the
upper limbs [N (%)]
No 12 (41.4)
Yes 17 (58.6)
Manual job [N (%)]
No 20 (69)
Yes 9 (31)
N: number of patients. IQR: interquartile range.
Table 2. Expression of Genes Involved in Collagen Cross-Linking and Its Regulation in the Glenohumeral Capsule of
Patients With Shoulder Instability and Controls
AI AS P
Gene
Cases
[DCrt;
Median
(IQR);
N¼ 29]
Controls
[DCrt;
Median
(IQR);
N¼ 8] p-value
Cases
[DCrt;
Median
(IQR);
N¼ 29]
Controls
[DCrt;
Median
(IQR);
N¼ 8] p-value
Cases
[DCrt;
Median
(IQR);
N¼ 29]
Controls
[DCrt;
Median
(IQR);
N¼ 8] p-value
LOX 2.64 (1.70) 3.37 (1.52) 0.285 2.65 (1.33) 3.18 (1.98) 0.104 2.55 (1.59) 3.36 (1.44) 0.058b
PLOD1 1.08 (0.61) 1.07 (0.47) 0.618 1.29 (0.40) 1.06 (0.72) 0.223 1.19 (0.52) 1.10 (0.42) 0.891
PLOD2 2.64 (0.85) 3.11 (1.08) 0.020a 2.66 (0.76) 2.61 (0.65) 0.968 2.59 (0.60) 2.85 (1.70) 0.089
TGFb1 0.75 (0.58) 0.58 (0.52) 0.605 0.93 (0.49) 0.77 (0.51) 0.133 0.89 (0.48) 0.82 (1.71) 0.785
TGFbR1 1.42 (0.40) 1.47 (0.73) 0.883 1.51 (0.93) 1.61 (0.19) 0.968 1.68 (0.88) 2.08 (0.76) 0.219
AI: antero-inferior portion of the glenohumeral capsule; AS: antero-superior portion of the glenohumeral capsule; P: posterior portion of
the glenohumeral capsule; IQR: interquartile range; N: number of samples. A lower delta cycle threshold value (DCrt) indicates higher
gene expression.aSignificant difference between groups by Mann–Whitney test (p<0.05). bA tendency to increased expression in
shoulder instability patients by Mann–Whitney test.
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indicative of the biomechanic tissue disorders. Fur-
thermore, the increased PLOD2 expression in this
region may be related to the continuation of the
symptoms and their recurrence.
PLOD2, TGFb1, and TGFbR1 may also have a role
in the disease etiology. We observed that the expres-
sion of these genes increases with the duration of
disease in the P region. PLOD2 seems to be regulated
by TGFb1.17 Moreover, previous studies have shown
that TGFbR1 is a key element in the regulation of
wound healing.35 Therefore, the continuation of symp-
toms may contribute to activation of the TGFb path-
way in the P region.
On the other hand, the expression of LOX seems to
be reduced with the disease. Although we observed
that LOX expression tended to be increased in the P
region of the patient’s capsule, its expression was
significantly higher in patients with only one disloca-
tion episode compared to controls and compared to
patients with recurrent dislocations. Moreover, this
gene expression was inversely correlated to the dura-
tion of symptoms in the macroscopically injured cap-
sule region. Thus, increased LOX expression seems to
be occurring in an initial phase of the disease.
Our previous study demonstrated the increased
expression of collagen fibrils genes across the capsule
Figure 1. Gene expression by number of dislocation episodes. (A) Increased TGFbR1 expression in the antero-inferior site of the
glenohumeral capsule of shoulder instability patients with more than 1 dislocation episode compared to patients with 1 dislocation
episode. (B) Increased PLOD2 expression in the posterior site of the glenohumeral capsule of shoulder instability patients with more
than 1 dislocation episode compared to patients with 1 dislocation episode. (C, B) Increased LOX expression in the posterior site of the
glenohumeral capsule of shoulder instability patients with 1 dislocation episode compared to patients with more than 1 dislocation
episode. 1 dislocation: gene expression in the capsule of patients who have experienced a single episode of shoulder dislocation (N¼ 6).
>1 dislocation: gene expression in the capsule of patients who have experienced more than one episode of shoulder dislocation (N¼23).
A lower delta cycle threshold value (DCrt) indicates higher gene expression. p-value <0.05 by Mann–Whitney test.
Figure 2. Correlation between gene expression and duration of shoulder instability symptoms (years). (A) LOX expression in the
antero-inferior site of the glenohumeral capsule. (B) TGFbR1 expression in the antero-inferior site of the glenohumeral capsule. (C)
PLOD2 expression in the posterior site of the glenohumeral capsule. (D) TGFb1 expression in the posterior site of the glenohumeral
capsule. (E) TGFbR1 expression in the posterior site of the glenohumeral capsule. A lower delta cycle threshold value (DCrt) indicates
higher gene expression; 29 samples of each capsule site was used for each statistical analysis.
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of shoulder instability patients compared to controls.5
It is generally accepted that the total amount of
enzymatic cross-linking is controlled by the expression
of LOX. Several previous studies have demonstrated
that collagen cross-link formation directly affects the
strength of bones, tendons, and ligaments.36,37 With
concomitant collagen upregulation, we should expect
LOX upregulation across the capsule. Therefore, the
lack of LOX upregulation suggests that the new
collagen fibrils may have reduced resistance to me-
chanical stress.
We observed that PLOD2 and TGFb1 were reduced
in the P portion and PLOD1 was reduced in the AS
portion of the capsule of patients who undertook
physical activity involving the upper limbs compared
to those who did not. It is widely reported that
physical activity involving the superior member can
lead to biomechanical and structural capsule modifica-
tions, such as capsular tightness, especially in the P
region.38 Although additional investigations are still
necessary, we hypothesize that these capsule modifica-
tions due to physical activity may explain the reduced
PLOD2, TGFb1, and PLOD1 expression in the capsule
of a subgroup of patients.
To our knowledge, this is the first study to evaluate
TGFb1, TGFbR1, LOX, PLOD1, and PLOD2 gene
expression in the glenohumeral capsule of shoulder
instability patients. However, this study has some
limitations. First, we evaluated a single time point (at
the time of surgical repair); thus, we were unable to
evaluate the dynamic regulation of gene expression. It
is not possible to perform a longitudinal gene expres-
sion study in a human capsule sample. Therefore, to
try to understand the modifications that occur with
time, we performed the statistical correlation analyses
between gene expression and duration of symptoms.
Second, although no significant intra-articular pathol-
ogy was detected in controls during the arthroscopic
examination, it is important to highlight that the
plastic deformation of the joint capsule cannot be
easily detected through an arthroscopic or clinical
exam. One other limitation concerns the tissue biopsy
collection. The synovium is adhered to the capsule and
cannot be separated from the capsule using arthro-
scopic instruments. The synovium may also contrib-
utes and influences the gene expression findings.
Finally, some statistical analyses exhibited reduced
power to detect significant differences between groups,
and this was most likely due to the high degree of
heterogeneity among patients with anterior shoulder
instability. Therefore, false-negative results may have
occurred.
In conclusion, we found increased PLOD2 expres-
sion in the macroscopically injured region of the
glenohumeral capsule of shoulder instability patients.
Upregulation of TGFb1, TGFbR1, and PLOD2 seem to
be related with the duration of symptoms, especially
in the P region of the capsule. LOX upregulation
seems to occur only in an initial phase of the disease.
Therefore, TGFb1, TGFbR1, LOX, and PLOD2 may
play a role in shoulder instability.
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